journal article·2023-12-31Open access

Novel curcumin nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells

Steve Harakeh, Saber H. Saber, Rajaa Al-Raddadi, Turki Alamri, Soad Al-Jaouni, Mohammed Qari, Yousef Qari, Shafiul Haque, Ayat Zawawi, Soad S. Ali, Zakaria Y. Abd Elmageed, Shaker Mousa

Abstract

Background Curcumin has been used in the treatment of several diseases; however, its low pharmacologic profile reduces its therapeutic use. Towards improving its biological activity, nanoformulations have emerged. Thus, we aimed to determine whether curcumin nanoparticles (Cur-NPs) coated with PEG/chitosan improve the treatment of liver cancer (LC) cells and underpin the molecular mechanisms underlying their anti-cancer activity.Methods Cur-NPs were synthesised in the form of Cur-PLGA-PEG/chitosan NPs. The effect of Cur-NPs was assessed in HepG2 and Huh 7 LC cells and THLE-2 normal liver cells.Results The size of synthesised Cur-NPS was determined in the standard range of 141.2 ± 47.5 nm. Compared to THLE-2 cells, LC cells treated with Cur-NPs exerted cytotoxicity at 6.25 µg/mL after 48h. Treatment of HepG-2 cells with 2.5 µg/mL of Cur-NPs inhibited cell migration and this inhibition was augmented at 10 µg/mL (p < 0.001). Treatment of chicken embryo with 5 µg/mL Cur-NPs reduced angiogenesis (p < 0.001) of 4-day-old embryos. The nanoformulation upregulated Bax and p53 and downregulated Bcl-2 in a concentration-dependent manner and subsequently induce apoptosis in HepG-2 cells.Conclusion Treatment of LC cells with Cur-NPs decreased cell proliferation, migration, and angiogenesis, and induced cell death by promoting the proapoptotic pathway.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Curcumin's Biomedical Applications · Phytochemical compounds biological activities · Cancer Research and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia

Yousef Abdul Latif Jameel Scientific Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

Laboratory of Molecular Cell Biology, Department of Zoology, Faculty of Science, Assiut University, Assiut, Egypt

Department of Community Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

Family and Community Medicine Department, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia

Department of Hematology/Pediatric Oncology, King Abdulaziz University Hospital, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

Department of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia

Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan, Saudi Arabia

Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia

Anatomy Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

Department of Pharmacology, Edward Via College of Osteopathic Medicine, University of LA at Monroe, Monroe, LA, USA

Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA

Funding

Institutional Fund Projects · Ministry of Education and King Abdulaziz University, Jeddah, Saudi Arabia.

References (55)

Show source-provided references
1. 10.3322/caac.2149210.3322/caac.21492 ↗
2. 10.1007/s00268-003-7182-610.1007/s00268-003-7182-6 ↗
3. 10.1002/hep.2093310.1002/hep.20933 ↗
4. 10.3322/canjclin.55.2.7410.3322/canjclin.55.2.74 ↗
5. 10.1016/j.bbrc.2015.10.03110.1016/j.bbrc.2015.10.031 ↗
6. 10.1038/nature0978110.1038/nature09781 ↗
7. 10.1016/j.semcancer.2012.03.00610.1016/j.semcancer.2012.03.006 ↗
8. 10.1038/s41571-018-0134-810.1038/s41571-018-0134-8 ↗
9. 10.1186/1476-4598-10-1210.1186/1476-4598-10-12 ↗
10. 10.3389/fphar.2020.0102110.3389/fphar.2020.01021 ↗
11. 10.3892/ol.2021.1254710.3892/ol.2021.12547 ↗
12. 10.1073/pnas.180679711510.1073/pnas.1806797115 ↗
13. 10.1186/s13046-018-0959-010.1186/s13046-018-0959-0 ↗
14. 10.1186/s13046-017-0661-710.1186/s13046-017-0661-7 ↗
15. 10.1186/s13046-017-0513-510.1186/s13046-017-0513-5 ↗
16. 10.3389/fphar.2016.0022310.3389/fphar.2016.00223 ↗
17. 10.2174/187152301466615040715053310.2174/1871523014666150407150533 ↗
18. 10.1080/10408398.2015.107719510.1080/10408398.2015.1077195 ↗
19. 10.2174/13892011279886879110.2174/138920112798868791 ↗
20. 10.1017/jns.2016.4310.1017/jns.2016.43 ↗
21. 10.1021/mp700113r10.1021/mp700113r ↗
22. 10.1186/s40580-021-00282-710.1186/s40580-021-00282-7 ↗
23. 10.1021/acs.bioconjchem.6b0043710.1021/acs.bioconjchem.6b00437 ↗
24. 10.18632/oncotarget.1615310.18632/oncotarget.16153 ↗
25. 10.2147/IJN.S22457910.2147/IJN.S224579 ↗
26. 10.2147/DDDT.S23895510.2147/DDDT.S238955 ↗
27. 10.1021/bm301732410.1021/bm3017324 ↗
28. 10.1016/j.ejpb.2008.06.01510.1016/j.ejpb.2008.06.015 ↗
29. 10.1016/j.ejphar.2011.09.02310.1016/j.ejphar.2011.09.023 ↗
30. 10.1016/j.bcp.2009.09.00310.1016/j.bcp.2009.09.003 ↗
31. 10.1038/s41598-021-81701-x10.1038/s41598-021-81701-x ↗
32. 10.5897/AJPP11.39310.5897/AJPP11.393 ↗
33. 10.3390/cancers1208230010.3390/cancers12082300 ↗
34. 10.3390/ijms1308995910.3390/ijms13089959 ↗
35. 10.1155/2019/516268710.1155/2019/5162687 ↗
36. 10.3923/ijp.2019.465.47710.3923/ijp.2019.465.477 ↗
37. 10.3390/nu1109214710.3390/nu11092147 ↗
38. 10.1080/10408347.2018.148921610.1080/10408347.2018.1489216 ↗
39. 10.1111/jphp.1261110.1111/jphp.12611 ↗
40. 10.1016/j.colsurfb.2012.06.02410.1016/j.colsurfb.2012.06.024 ↗
41. 10.2217/nnm-2021-006610.2217/nnm-2021-0066 ↗
42. 10.1016/j.biopha.2018.03.10110.1016/j.biopha.2018.03.101 ↗
43. 10.1021/mp500222k10.1021/mp500222k ↗
44. 10.3109/21691401.2016.114673610.3109/21691401.2016.1146736 ↗
45. 10.1016/j.ijpharm.2010.08.03310.1016/j.ijpharm.2010.08.033 ↗
46. 10.1016/j.apsb.2015.07.00510.1016/j.apsb.2015.07.005 ↗
47. 10.1016/j.addr.2007.04.01910.1016/j.addr.2007.04.019 ↗
48. 10.1007/s10456-014-9440-710.1007/s10456-014-9440-7 ↗
49. 10.1007/s43440-021-00218-210.1007/s43440-021-00218-2 ↗
50. 10.3390/nano1004069810.3390/nano10040698 ↗
51. 10.3892/ijo.2013.205010.3892/ijo.2013.2050 ↗
52. 10.3390/molecules1705597210.3390/molecules17055972 ↗
53. 10.1007/s00210-020-01888-010.1007/s00210-020-01888-0 ↗
54. 10.3390/molecules2705160510.3390/molecules27051605 ↗
55. 10.1002/tox.2301610.1002/tox.23016 ↗